|
Partial dopamine receptor agonism treatment of schizophrenia
Associate Professor Trevor Norman, University of Melbourne, Australia
|
|
Advances in the pharmacotherapy of schizophrenia: Short-term trials with new antipsychotic agents
Professor Nicholas A Keks, Mental Health Reserach Insitute of Victoria, Australia
|
|
New pharmacologic approaches to improving long-term outcomes in patients with schizophrenia
Stephen R Marder, David Gegen School of Medicine at UCLA, United States
|
|
Antipsychotic medications – where are we now?
Professor Jayashri Kulkarni, Alfred Hospital, Australia
|
|
Efficacy and safety of a new antipsychotic with a unique mechanism of action in the treatment of mania
Professor Siegfried Kasper, University of Vienna, Austria
|